AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trevitt, C. R
Right arrow Articles by Singh, P. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trevitt, C. R
Right arrow Articles by Singh, P. N
Agricola
Right arrow Articles by Trevitt, C. R
Right arrow Articles by Singh, P. N
American Journal of Clinical Nutrition, Vol. 78, No. 3, 651S-656S, September 2003
© 2003 American Society for Clinical Nutrition


Supplements

Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications1,2,3,4

Clare R Trevitt and Pramil N Singh

1 From the MRC Prion Unit, Division of Neuroscience, Faculty of Medicine, Imperial College, Norfolk Place, London (CRT), and the Department of Epidemiology and Biostatistics, School of Public Health, Loma Linda University, Loma Linda, CA (PNS).

Prion diseases, or transmissible spongiform encephalopathies, include Creutzfeldt-Jakob disease (CJD) in humans and scrapie and bovine spongiform encephalopathy (BSE) in animals. These neurodegenerative diseases are invariably fatal and can be transmitted by inoculation or dietary exposure. They are associated with the accumulation of an altered, disease-associated form of the normal prion protein. Pathologically, prion diseases result in neuronal cell death and a characteristic spongiform appearance of the brain tissue. The emergence of a variant form of CJD (vCJD) in the United Kingdom in 1996 has been causally and experimentally linked to the UK BSE epidemic in the 1980s and early 1990s. The finding that BSE is transmissible to different animal species, unlike previously characterized prion diseases such as sheep scrapie, has raised enormous public health concerns worldwide. Although it is not yet possible to gauge the size of a potential vCJD epidemic, preliminary data indicate a significant dietary exposure to BSE-infected material in Britain and wider implications of the transmissibility of prion diseases. The threat to public health has intensified research efforts to understand the molecular basis of prion diseases, understand their transmission between species, improve methods of diagnosis, and develop therapeutic strategies for treatment and prevention of disease. In this review, we summarize current data on the pathology of BSE and vCJD and the epidemiology of vCJD, and we outline public health implications based on these data, emphasizing preventative measures and areas of research for screening and diagnosis.

Key Words: Variant Creutzfeldt-Jakob disease • spongiform encephalopathy • prion disease • meat




This article has been cited by other articles:


Home page
J. Med. EthicsHome page
R E Duncan, M B Delatycki, S J Collins, A Boyd, C L Masters, and J Savulescu
Ethical considerations in presymptomatic testing for variant CJD
J. Med. Ethics, November 1, 2005; 31(11): 625 - 630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition